Clinical research of flupentixol-melitracen and mesalazine on ulcerative colitis

• Register: ChiCTR
• Last refreshed on: 5 June 2018
• Main ID: ChiCTR1800016438
• Date of registration: 2018-06-01
• Prospective Registration: Yes
• Primary sponsor: Guiyang 1st People's Hospital
• Public title: Clinical research of flupentixol-melitracen and mesalazine on ulcerative colitis
• Scientific title: Clinical research of flupentixol-melitracen and mesalazine on ulcerative colitis
• Date of first enrolment: 2018-06-30
• Target sample size: control:30;observation group:30;
• Recruitment status: Pending
• URL: http://www.chictr.org.cn/showproj.aspx?proj=27574
• Study type: Treatment study
• Study design: Case-Control study
• Phase: Pilot study

Countries of recruitment

China

Contacts

• Name: ZHOU XIAOQIAN
• Affiliation: Guiyang 1st People's Hospital

• Name: ZHOU XIAOQIAN
• Affiliation: Guiyang 1st People's Hospital

Key inclusion & exclusion criteria

Inclusion criteria: ???????????(DAI 3-10?)????????3-10?(HADS0-7?)
Exclusion criteria: UC patients with Severe activity (DAI 11-12 point) OR without Severe anxiety/depression (HADS 0 -7 point) will be excluded.

Age minimum: 15
Age maximum: 75
Gender: Both

Health Condition(s) or Problem(s) studied

ulcerative colitis

Intervention(s)

control:mesalazine 1 po qid;observation group:mesalazine 1 po qid; flupentixol-melitracen 1pill po tid;

Primary Outcome(s)

EFFECT OF TREATMENT;DAI;HADS;

Source(s) of Monetary Support

TECHNOLOGY FOUNDATION OF GUIYANG (20061001)

Ethics review

Status: Approved
Approval date: 26/08/2017
Contact:

SHI JIAN